CRISPR-Cas9 Gene Editing of the Sal1 Gene Family in Wheat

被引:16
|
作者
Mohr, Toni [1 ]
Horstman, James [1 ]
Gu, Yong Q. [1 ]
Elarabi, Nagwa I. [2 ]
Abdallah, Naglaa A. [2 ]
Thilmony, Roger [1 ]
机构
[1] ARS, USDA, Crop Improvement & Genet Unit, Albany, CA 94710 USA
[2] Cairo Univ, Fac Agr, Dept Genet, Giza 12613, Egypt
来源
PLANTS-BASEL | 2022年 / 11卷 / 17期
关键词
CRISPR; wheat; Sal1; drought tolerance; Triticum aestivum; gene editing; TARGETED MUTAGENESIS; ARABIDOPSIS; DROUGHT; EXPRESSION; RNA; TOLERANCE; STRESS;
D O I
10.3390/plants11172259
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
The highly conserved Sal1 encodes a bifunctional enzyme with inositol polyphosphate-1-phosphatase and 3' (2'), 5'-bisphosphate nucleotidase activity and has been shown to alter abiotic stress tolerance in plants when disrupted. Precise gene editing techniques were used to generate Sal1 mutants in hexaploid bread wheat. The CRISPR (Clustered Regulatory Interspaced Short Palindromic Repeats) Cas9 system with three guide RNAs (gRNAs) was used to inactivate six Sal1 homologous genes within the Bobwhite wheat genome. The resulting mutant wheat plants with all their Sal1 genes disabled had slimmer stems, had a modest reduction in biomass and senesced more slowly in water limiting conditions, but did not exhibit improved yield under drought conditions. Our results show that multiplexed gRNAs enabled effective targeted gene editing of the Sal1 gene family in hexaploid wheat. These Sal1 mutant wheat plants will be a resource for further research studying the function of this gene family in wheat.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] Gene Editing and Crop Improvement Using CRISPR-Cas9 System
    Arora, Leena
    Narula, Alka
    FRONTIERS IN PLANT SCIENCE, 2017, 8
  • [22] CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
    Frangoul, H.
    Altshuler, D.
    Cappellini, M. D.
    Chen, Y-S
    Domm, J.
    Eustace, B. K.
    Foell, J.
    de la Fuente, J.
    Grupp, S.
    Handgretinger, R.
    Ho, T. W.
    Kattamis, A.
    Kernytsky, A.
    Lekstrom-Himes, J.
    Li, A. M.
    Locatelli, F.
    Mapara, M. Y.
    de Montalembert, M.
    Rondelli, D.
    Sharma, A.
    Sheth, S.
    Soni, S.
    Steinberg, M. H.
    Wall, D.
    Yen, A.
    Corbacioglu, S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (03): : 252 - 260
  • [23] Application of CRISPR-Cas9 gene editing for congenital heart disease
    Seok, Heeyoung
    Deng, Rui
    Cowan, Douglas B.
    Wang, Da-Zhi
    CLINICAL AND EXPERIMENTAL PEDIATRICS, 2021, 64 (06) : 269 - 279
  • [24] Reversible RNA acylation for control of CRISPR-Cas9 gene editing
    Habibian, Maryam
    McKinlay, Colin
    Blake, Timothy R.
    Kietrys, Anna M.
    Waymouth, Robert M.
    Wender, Paul A.
    Kool, Eric T.
    CHEMICAL SCIENCE, 2020, 11 (04) : 1011 - 1016
  • [25] CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy
    Fontana, Marianna
    Solomon, Scott D.
    Kachadourian, Jessica
    Walsh, Liron
    Rocha, Ricardo
    Lebwohl, David
    Smith, Derek
    Taubel, Jorg
    Gane, Edward J.
    Pilebro, Bjorn
    Adams, David
    Razvi, Yousuf
    Olbertz, Joy
    Haagensen, Alexandra
    Zhu, Peijuan
    Xu, Yuanxin
    Leung, Adia
    Sonderfan, Alison
    Gutstein, David E.
    Gillmore, Julian D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (23): : 2231 - 2241
  • [26] Therapeutic gene editing strategies using CRISPR-Cas9 for the β-hemoglobinopathies
    Papizan, James B.
    Porter, Shaina N.
    Sharma, Akshay
    Pruett-Miller, Shondra M.
    JOURNAL OF BIOMEDICAL RESEARCH, 2021, 35 (02): : 115 - 134
  • [27] CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
    Mehta, Jayesh
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (23):
  • [28] CRISPR-Cas9 gene editing: Delivery aspects and therapeutic potential
    Blenke, Erik Oude
    Evers, Martijn J. W.
    Mastrobattista, Enrico
    van der Oost, John
    JOURNAL OF CONTROLLED RELEASE, 2016, 244 : 139 - 148
  • [29] Modelling the Cancer Phenotype in the Era of CRISPR-Cas9 Gene Editing
    Stewart, J.
    Banerjee, S.
    Pettitt, S. J.
    Lord, C. J.
    CLINICAL ONCOLOGY, 2020, 32 (02) : 69 - 74
  • [30] Recent Progress in Regulating CRISPR-Cas9 System for Gene Editing
    Gong Shaohua
    Li Na
    Tang Bo
    ACTA CHIMICA SINICA, 2020, 78 (07) : 634 - 641